Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test
On 11 March 2020, WHO declared the SARS-CoV-2 outbreak as a pandemic, representing a public health emergency of unprecedented dimension. COVID-19 is a multisystem Novel viral infection with protean manifestations and variable degrees of clinical presentation. The most common presentation is upper an...
Main Authors: | Oghowan Abdelrahman, Andleeb Shadan, Laila Al Dabal, Tasnim R. Keloth |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-04-01
|
Series: | Dubai Medical Journal |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/514069 |
Similar Items
-
Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
by: Dana Blyth, et al.
Published: (2012-01-01) -
An uncommon coexistence of sarcoidosis and cutaneous leukocytoclastic vasculitis in an adult
by: Birsen Ocakli, et al.
Published: (2019-01-01) -
Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report
by: Serhat Sayin, et al.
Published: (2018-03-01) -
Cutaneous leukocytoclastic vasculitis: the roleof lymphocytes and related immune markers
by: Thilo Gambichler, et al.
Published: (2017-08-01) -
Leukocytoclastic vasculitis in T‐cell lymphoma
by: Ming Y. Lim
Published: (2020-12-01)